脑小血管病研究进展

doi:10.3969/j.issn.1673-5765.2017.02.009

摘要/Abstract

摘要：

近年来，随着人口老龄化的加剧，脑小血管病（cerebral small vessel disease，CSVD）也日益增多。CSVD可引起一系列病理学、神经影像学变化及相关临床症状，是导致老年人认知功能下降和功能缺失的一大原因，本文就近年来CSVD在病理学、临床和影像学特征及诊疗方面的研究进展进行综述，以期为其进一步研究提供思路。

文章导读： 随着许多针对CSVD病理、临床特点等多层次、多方位研究的开展以及影像技术的革新，CSVD在不远的将来可实现有效的可防可控。

关键词: 脑小血管病; 病理学; 神经影像学; 临床特征; 治疗

Abstract:

Recently, the amount of cerebral small vessel disease (CSVD) has enormously increased along with the aging population. CSVD could cause a range of pathologies and neuroimaging changes, and associated clinical manifestations, which is a major cause for cognitive decline and functional loss in the elderly. This paper reviewed the research of CSVD in recent years in pathologies, clinical and imaging, diagnosis and therapeutics, so as to provide ideas for further research.

Key words: Cerebral small vessel disease; Pathologies; Neuroimaging; Clinical characteristics; Therapeutics

陶雯，柯开富. 脑小血管病研究进展[J]. 中国卒中杂志, 2017, 12(02): 147-151.

TAO Wen, KE Kai-Fu. Research Progress of Cerebral Small Vessel Disease[J]. Chinese Journal of Stroke, 2017, 12(02): 147-151.

参考文献

1 Thompson CS，Hakim AM. Living beyond our

physiological means：small vessel disease of the brain

is an expression of a systemic failure in arteriolar

function：a unifying hypothesis[J]. Stroke，2009，40：

e322-e330.

2 Pantoni L. Cerebral small vessel disease：from

pathogenesis and clinical characteristics to therapeutic

challenges[J]. Lancet Neurol，2010，9：689-701.

3 Dichgans M. Genetics of ischaemic stroke[J]. Lancet

Neurol，2007，6：149-161.

4 Ballabio E，Bersano A，Bresolin N，et al. Monogenic

vessel diseases related to ischemic stroke：a clinical

approach[J]. J Cereb Blood Flow Metab，2007，27：

1649-1662.

5 Wa rdlaw JM，Smi th EE，Bies sels GJ，e t a l .

Neuroimaging standards for research into small

vessel disease and its contribution to ageing and

neurodegeneration[J]. Lancet Neurol，2013，12：822-

838.

6 Keir SL，Wardlaw JM，Bastin ME，et al. In which

patients is diffusion-weighted magnetic resonance

imaging most useful in routine stroke care?[J]. J

Neuroimaging，2004，14：118-122.

7 Benjamin P，Viessmann O，Mackinnon AD，et al. 7

Tesla MRI in cerebral small vessel disease[J]. Int J

Stroke，2015，10：659-664.

8 Patel B，Markus HS. Magnetic resonance imaging in

cerebral small vessel disease and its use as a surrogate

disease marker[J]. Int J Stroke，2011，6：47-59.

9 van Veluw SJ，Jolink WM，Hendrikse J，et al.

Cortical microinfarcts on 7T MRI in patients with

spontaneous intracerebral hemorrhage[J]. J Cereb

Blood Flow Metab，2014，34：1104-1106.

10 Madai VI，von Samson-Himmelstjerna FC，Bauer M，

et al. Ultrahigh-field MRI in human ischemic stroke

--a 7 tesla study[J]. PLoS One，2012，7：e37631.

11 Theysohn JM，Kraff O，Maderwald S，et al. 7 tesla

MRI of microbleeds and white matter lesions as seen

in vascular dementia[J]. J Magn Reson Imaging，2011，

33：782-791.

12 Sudlow CL，Warlow CP. Comparable studies of the

incidence of stroke and its pathological types：results

from an international collaboration. International

Stroke Incidence Collaboration[J]. Stroke，1997，28：

491-499.

13 O'Sullivan M，Mor r is RG，Markus HS. Br ief

cognitive assessment for patients with cerebral small

vessel disease[J]. J Neurol Neurosurg Psychiatry，

2005，76：1140-1145.

14 Koga H，Takashima Y，Murakawa R，et al. Cognitive

consequences of multiple lacunes and leukoaraiosis as

vascular cognitive impairment in community-dwelling

elderly individuals[J]. J Stroke Cerebrovasc Dis，2009，

18：32-37.

15 Yakushiji Y，Nishiyama M，Yakushiji S，et al. Brain

microbleeds and global cognitive function in adults

without neurological disorder[J]. Stroke，2008，39：

3323-3328.

16 Pantoni L，Poggesi A，Inzitari D. The relation

between white-matter lesions and cognition[J]. Curr

Opin Neurol，2007，20：390-397.

17 LADIS Study Group. 2001-2011：a decade of the

LADIS (Leukoaraiosis And Disability) Study：what

have we learned about white matter changes and

small-vessel disease?[J]. Cerebrovasc Dis，2011，32：

577-588.

18 Jokinen H，Kalska H，Ylikoski R，et al. Longitudinal

cognitive decline in subcortical ischemic vascular

disease--the LADIS Study[J]. Cerebrovasc Dis，2009，

27：384-391.

19 Yamaguchi Y，Wada M，Sato H，et al. Impact of

ambulatory blood pressure variability on cerebral

small vessel disease progression and cognitive decline

in community-based elderly Japanese[J]. Am J

Hypertens，2014，27：1257-1267.

20 Rothwell PM，Howard SC，Dolan E，et al. Effects of

beta blockers and calcium-channel blockers on withinindividual

variability in blood pressure and risk of

stroke[J]. Lancet Neurol，2010，9：469-480.

21 Rothwell PM. Limitations of the usual blood-pressure

hypothesis and importance of variability，instability，

and episodic hypertension[J]. Lancet，2010，375：938-

948.

22 Gorelick PB，Scuteri A，Black SE，et al. Vascular

contributions to cognitive impairment and dementia：

a statement for healthcare professionals from the

Amer ican Heart Association/Amer ican Stroke

Association[J]. Stroke，2011，42：2672-2713.

能下降[29]。

CSVD发病隐匿且临床表现多种多样不易

识别，伴随人口老龄化问题，CSVD导致许多

老年人出现认知、精神和肢体功能障碍，发病

率呈上升趋势，随着医学诊疗水平的不断发展

和人群健康意识的不断提高，早期发现并防治

CSVD意义重大。

中国卒中杂志 2017年２月第12卷第２期 151

23 Neumann-Haefelin T，Hoelig S，Berkefeld J，et

al. Leukoaraiosis is a risk factor for symptomatic

intracerebral hemorrhage after thrombolysis for acute

stroke[J]. Stroke，2006，37：2463-2466.

24 Pantoni L，Fierini F，Poggesi A. Thrombolysis in

acute stroke patients with cerebral small vessel

disease[J]. Cerebrovasc Dis，2014，37：5-13.

25 Uchiyama S. Results of the Cilostazol St roke

Prevention Study Ⅱ (CSPS Ⅱ)：a randomized

controlled trial for the comparison of cilostazol and

aspirin in stroke patients[J]. Rinsho Shinkeigaku，

2010，50：832-834.

26 Kav i r ajan H，Sch nei d e r LS. Ef f i c a c y a nd

adverse effects of cholinesterase inhibitors and

memantine in vascular dementia：a meta-analysis

of randomised controlled trials[J]. Lancet Neurol，

2007，6：782-792.

27 Auchus AP，Brashear HR，Salloway S，et a l.

Galantamine treatment of vascular dementia：a

randomized trial[J]. Neurology，2007，69：448-458.

28 Wilcock G，Möbius HJ，Stöffler A. A double-blind，

placebo-controlled multicentre study of memantine

in mild to moderate vascular dementia (MMM500)[J].

Int Clin Psychopharmacol，2002，17：297-305.

29 Pantoni L，del Ser T，Soglian AG，et al. Efficacy and

safety of nimodipine in subcortical vascular dementia：

a randomized placebo-controlled trial[J]. Stroke，

2005，36：619-624.

[1]	宋彦丽, 林杰, 武一平, 李晓晶, 刘改芬, 夏文静, 张玉英, 张晓林, 吕晨冉, 周红, 李凯, 薛斌, 陈玲玲, 张忠波, 彭晓. 邯郸市居民心脑血管病危险因素的流行现状及高血压知晓率、治疗率和控制率的影响因素研究 [J]. 中国卒中杂志, 2022, 17(12): 1360-1365.
[2]	郑占军, 赵性泉. 脑小血管病影像学标志物与自发性高血压脑出血的相关性研究进展[J]. 中国卒中杂志, 2022, 17(12): 1396-1402.
[3]	王磊, 周春亭, 方洋, 王朝晖. 2例椎动脉漂浮血栓的治疗体会[J]. 中国卒中杂志, 2022, 17(11): 1247-1251.
[4]	程实, 李静, 郭军平, 胡爱香, 于鑫玮, 韩玮, 梁瑛, 张越巍, 冀瑞俊. 急性卒中患者住院期间感染的临床特征及危险因素分析[J]. 中国卒中杂志, 2022, 17(10): 1065-1070.
[5]	韩广淞, 倪俊. 烟雾病临床分型研究进展[J]. 中国卒中杂志, 2022, 17(10): 1120-1126.
[6]	符荷琯, 沈栩轩, 徐佳丽, 张厚地, 李斌, 邹正兴, 冯捷, 段炼, 韩聪. 青年烟雾病患者的卒中类型及危险因素分析 [J]. 中国卒中杂志, 2022, 17(09): 937-943.
[7]	曹雨停, 范文娟, 王春雪, 陈瑛. 绝经激素治疗与卒中相关性的meta分析 [J]. 中国卒中杂志, 2022, 17(09): 957-965.
[8]	冯博, 赵彩君, 常立国. 基于快速CYP2C19基因检测发现携带功能缺失等位基因的急性轻型缺血性卒中双抗治疗1例报道[J]. 中国卒中杂志, 2022, 17(08): 817-820.
[9]	刘承春, 唐春花, 黄书翰, 吴娅, 李小树, 李玮, 张猛. 伴大核心梗死的前循环串联闭塞的急性期同期血管内治疗研究[J]. 中国卒中杂志, 2022, 17(08): 834-839.
[10]	中国卒中学会神经介入分会. 症状性颅内动脉粥样硬化性狭窄血管内治疗中国专家共识2022[J]. 中国卒中杂志, 2022, 17(08): 863-888.
[11]	刘子悦, 朱以诚. 院内卒中再灌注治疗研究进展[J]. 中国卒中杂志, 2022, 17(07): 695-705.
[12]	洪月慧, 韩广淞, 吴娟娟, 沙宇惠, 付瀚辉, 周立新, 朱以诚, 倪俊. 优化院内卒中救治体系对院内缺血性卒中再灌注治疗与预后的影响：单中心回顾性研究[J]. 中国卒中杂志, 2022, 17(07): 706-710.
[13]	郑玮, 翟华筝, 陈萌萌, 汪敬业. 直接取栓与桥接治疗对急性大血管闭塞性缺血性卒中疗效比较的荟萃分析[J]. 中国卒中杂志, 2022, 17(07): 720-729.
[14]	崔晓玉, 聂曦明, 刘丽萍. 急性缺血性卒中血管内治疗术后血清前白蛋白水平与预后的相关性研究[J]. 中国卒中杂志, 2022, 17(07): 758-763.
[15]	陈超, 万慧娟, 董文玉, 王圣松, 余苹, 邵晓秋. 脑小血管病总负荷与中老年癫痫患者认知功能的相关性[J]. 中国卒中杂志, 2022, 17(06): 622-627.